Nexien BioPharma (NXEN) Short Interest Ratio & Short Volume

Short interest is the volume of Nexien BioPharma shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 500 shares of NXEN short. 0.00% of Nexien BioPharma's shares are currently sold short. Learn More on Nexien BioPharma's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Nexien BioPharma's floating shares are currently sold short.

0.00% of Nexien BioPharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Nexien BioPharma: Qualigen Therapeutics, Inc. (7.49%), NovaBay Pharmaceuticals, Inc. (3.31%), Aspira Women's Health Inc. (1.19%), Revelation Biosciences, Inc. (13.10%), Psyence Biomedical Ltd. (33.19%), Evaxion Biotech A/S (1.83%), Scinai Immunotherapeutics Ltd. (0.24%), Vaccinex, Inc. (5.39%), PainReform Ltd. (17.37%), Shuttle Pharmaceuticals Holdings, Inc. (21.28%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

Short selling NXEN is an investing strategy that aims to generate trading profit from Nexien BioPharma as its price is falling. NXEN shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Nexien BioPharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NXEN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NXEN, twice per month. The most recent reporting period available is April, 15 2025.